WINDTREE THERAPEUTICS INC /DE/ Shareholders' Equity
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Shareholders' Equity of -$11.61 million as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-11-19
- 2025-09-30: Stockholders' Equity Attributable to Parent -$11.61M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $3.61M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $10.29M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $10.00M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-09-30 | -$11.61M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $3.61M 10-Q · filed 2025-11-19 | |
| 2025-03-31 | $10.29M 10-Q · filed 2025-11-19 | |
| 2024-12-31 | $10.00M 10-Q · filed 2025-11-19 | |
| 2024-09-30 | $4.41M 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $3.49M 10-Q · filed 2025-11-19 | |
| 2024-03-31 | $15.42M 10-Q · filed 2025-11-19 | |
| 2023-12-31 | $3.39M 10-Q · filed 2025-11-19 | |
| 2023-09-30 | $7.48M 10-Q · filed 2024-11-26 | |
| 2023-06-30 | $11.60M 10-Q · filed 2024-11-26 | |
| 2023-03-31 | $7.03M 10-Q · filed 2024-11-26 | |
| 2022-12-31 | $10.01M 10-K · filed 2025-04-15 | |
| 2022-09-30 | $17.42M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $19.20M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $34.73M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $41.88M 10-K · filed 2024-04-16 | |
| 2021-09-30 | $50.18M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $56.76M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $91.49M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $69.55M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $75.72M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $83.46M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $70.09M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $74.94M 10-K · filed 2022-03-31 | |
| 2019-09-30 | $53.07M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $58.27M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $63.00M 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $68.11M 10-K · filed 2021-03-29 | |
| 2018-09-30 | -$31.33M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$28.38M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | -$28.07M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | -$23.92M 10-K · filed 2020-04-03 | |
| 2017-09-30 | -$37.45M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$32.18M 10-Q · filed 2017-08-21 | |
| 2017-03-31 | -$25.76M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$28.83M 10-K/A · filed 2019-04-23 | |
| 2016-09-30 | -$22.85M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$15.22M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | -$5.00M 10-Q · filed 2016-11-14 | -$4.98M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $8.27M 10-K · filed 2018-04-17 | |
| 2015-09-30 | $17.89M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$3.08M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $7.81M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $19.20M 10-K · filed 2017-03-31 | |
| 2014-09-30 | $28.96M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $39.21M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $48.81M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $58.50M 10-K · filed 2016-03-29 | |
| 2013-09-30 | $5.47M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $16.82M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $9.46M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $17.65M 10-K · filed 2015-03-16 | |
| 2012-09-30 | $23.05M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $35.70M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $42.23M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.26M 10-K · filed 2015-03-16 | |
| 2011-09-30 | $4.73M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $9.21M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $6.03M 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |